Brainlab debuts SmartBrush Angio software October 22, 2014 -- Image-guided therapy firm Brainlab's Elements SmartBrush Angio software has been used clinically for the first time to correlate a patient's diagnostic datasets with temporal and spatial information.
Barco unites medical displays with Uniti launch at JFR October 16, 2014 -- In the world of medical displays, a gulf has existed between grayscale and color, with imaging facilities maintaining separate types of monitors for optimal performance. At the French national congress, JFR, Barco aims to bridge the divide through Coronis Uniti, designed for both applications.
Consent problems hold back fetal autopsies October 15, 2014 -- Global researchers who are eager to gain experience in fetal autopsies using CT and MRI are facing immense frustration due to ongoing difficulties over obtaining consent, and one investigator reports being "hamstrung" by the procedures and bureaucracy of ethics committees.
Spanish newcomer shakes up advanced visualization market October 6, 2014 -- A start-up firm in Madrid is fomenting something of a revolution in how advanced visualization software is developed and implemented. MedimSight is in the business of helping developers and users worldwide find each other on a website and in the cloud.
3D CT reveals brain damage in Paleolithic youth October 6, 2014 -- Detailed high-resolution 3D 256-detector-row CT images have opened a fascinating window onto the life of a teenager who lived in what is now northern Israel and who suffered severe head trauma 100,000 years ago, according to a French anthropologist.
Peripheral artery disease gets its own CAD October 3, 2014 -- Researchers in Switzerland and the U.K. have built a computer-aided detection (CAD) system that locates and measures peripheral artery disease based on the size of the lumen and the degree of stenosis. The system has been tested on a phantom and in 15 patients.
Survey: Patients unfazed by false positives on CTC exams October 2, 2014 -- In a new survey, patients said they believe the benefits of having a malignancy detected on colon screening exams more than outweigh the drawbacks of a false positive, even if it would lead to unnecessary imaging or invasive follow-up, according to a group of leading experts from the U.K.